| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 05/24/2005 | US6897310 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction |
| 05/24/2005 | US6897225 Inhibitors of αLβ2 mediated cell adhesion |
| 05/24/2005 | US6897223 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/19/2005 | WO2005044822A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/19/2005 | WO2004106492A3 Bicyclicpyrimidones and their use to treat diseases |
| 05/19/2005 | WO2004050645A8 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 05/19/2005 | US20050107449 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X |
| 05/19/2005 | US20050107431 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 05/19/2005 | US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/19/2005 | DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/18/2005 | EP1530574A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 05/18/2005 | CN1617666A Fused heterocyclic sulfonylurea compound, herbicide containing the same and method of controlling weed with the same |
| 05/17/2005 | CA2301967C Azetidinone derivatives for the treatment of hcmv infections |
| 05/12/2005 | WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 05/12/2005 | WO2004064778A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/12/2005 | US20050101646 Tyrosine kinase inhibitor; antiproliferative agents; controlling signal transduction; anticancer agents |
| 05/12/2005 | US20050101626 Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/12/2005 | US20050101595 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use |
| 05/12/2005 | US20050101592 3-(4-chlorophenyl)-2-(2-chlorophenyl)-7-(2,2,2-trifluoroethyl)-6,7-dihydro-2H,5H-4-oxa-1,2,7-triaza-azulen-8-one; for treatment of disorders linked to mediation of cannabinoid receptors |
| 05/12/2005 | US20050101590 Cannabinoid receptor agonists |
| 05/11/2005 | CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 05/11/2005 | CN1615299A Xanthine oxidase inhibitors |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040173A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 05/06/2005 | WO2005039589A2 Cftr channel modulators |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2540817A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 05/05/2005 | US20050096364 Iminothiazolidinones as inhibitors of HCV replication |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096347 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | CN1199975C Preparatio method of prolisaxin |
| 05/03/2005 | US6887884 For therapy of neurological and psychological disorders |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 04/28/2005 | WO2005037845A1 Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
| 04/28/2005 | WO2005037844A1 Substituted phenyl fused heterocycles as high efficiency herbicides |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005007630A3 Aryl fused azapolycyclic compounds |
| 04/28/2005 | US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542113A1 Compositions useful as inhibitors of protein kinases |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | CN1609110A High efficiency substituted benzene fused heterocycle herbicides |
| 04/26/2005 | US6885026 Organic element for electroluminescent devices |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/21/2005 | WO2005035533A1 Modulators of serotonin receptors |
| 04/21/2005 | WO2005035526A1 Bicyclic compounds and their therapeutic use |
| 04/21/2005 | WO2005035505A2 Compounds with phosphodiesterase inhibiting and calcium channel blocking activities |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085494 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/20/2005 | EP1523486A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/14/2005 | WO2005033115A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | US20050080074 Such as (+-)-1,3,4,10b-tetrahydro-7-trifluoromethoxy-pyrazino[2,1-a]isoindol-6(2H)-one for treatment of metabolic disorders, central nervous system disorders, and gastrointestinal disorders |
| 04/14/2005 | US20050079387 Imidazole ring-containing compound and organic electroluminescence display device |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | CA2541533A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606559A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/12/2005 | US6878715 Xanthine derivatives such as 1-(5-N,N-dimethylaminohexyl)-3,7-dimethylxanthine |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/07/2005 | WO2005030796A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075363 Microbiocides, bactericides, fungicides, and antiprotozoa agents; beta-lactamase inhibitors |
| 04/07/2005 | US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one |
| 04/07/2005 | US20050074632 electrical stability, better charge transporting capability, a high glass transition temperature, and does not crystallize; high-efficiency, low-voltage, high-luminance, long-lifespan; durability; color purity |
| 04/07/2005 | CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519929A1 2,1,3-benzothiadiazoles for use as electronic active components |
| 04/06/2005 | EP1465882A4 Hetrocyclic modulators of nuclear receptors |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875762 Tetracyclic azepinoindole compounds |
| 03/31/2005 | WO2005028484A1 Thiazolopyridine derivatives as adenosine receptor ligands |
| 03/31/2005 | WO2005028478A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 03/31/2005 | US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/31/2005 | US20050069522 Combination pharmaceutical agents as inhibitors of HCV replication |
| 03/31/2005 | US20050069492 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 03/31/2005 | CA2539314A1 Thiazolopyridine derivatives as adenosine receptor ligands |
| 03/31/2005 | CA2537325A1 Aza-quinolinol phosphonate integrase inhibitor compounds |